Sonoma Pharmaceutical’s antimicrobial gel received 510(k) clearance from the FDA to treat the skin of post-nonablative laser therapy and post-microdermabrasion therapy patients, in addition to treating post-superficial chemical peels.

The product is intended for dermatologists and aesthetic clinicians to manage medical procedures and post-procedure itch and pain associated with procedures like laser skin resurfacing.

The antimicrobial gel promotes advanced healing and protection against secondary infections that could occur after treatment.